Related Experiment Videos
[Micro-Ebstein. Presentation of 3 cases and analysis of the literature]
Abstract:
The authors describe three cases of micro-Ebstein diagnosed using 2D-echocardiography in patients affected by extrasystolic cardiopalm. The most important echocardiographic criterion for diagnosis was an apical displacement of the septal cusp of the tricuspid valve of at least 8 mm/m2 BA. It is generally reported that the severity of arrhythmias is independent of the degree of tricuspid malformation. The anatomical substrates of arrhythmias are persistent anomalous muscular by-passes between the atrium and the ventricles, and intrinsic anomaly of the right ventricular myocardium. For these reasons, it is necessary to follow-up patients and monitor arrhythmias using Holter-ECG. Echocardiography is now recognised as being the most important tool for the identification of this anomaly.
Insights
Micro-Ebstein anomaly, a rare heart condition, is diagnosed using 2D-echocardiography. Key diagnostic criteria include significant apical displacement of the tricuspid valve, aiding in early detection and management of associated arrhythmias.
Area of Science:
- Cardiology
- Medical Imaging
- Clinical Diagnostics
Background:
- Micro-Ebstein anomaly is a rare congenital heart condition.
- Extrasystolic cardiomyopathy can be associated with tricuspid valve abnormalities.
- Accurate diagnosis is crucial for managing potential arrhythmias.
Observation:
- Three cases of micro-Ebstein anomaly were diagnosed using 2D-echocardiography.
- A key diagnostic criterion was apical displacement of the septal tricuspid valve cusp (≥ 8 mm/m2 BA).
- Arrhythmia severity appeared independent of the degree of tricuspid malformation.
Findings:
- 2D-echocardiography is the primary tool for identifying micro-Ebstein anomaly.
- Anomalous muscular bypass tracts and intrinsic right ventricular myocardial anomalies contribute to arrhythmias.
- Apical displacement of the septal tricuspid valve cusp is a significant diagnostic marker.
Implications:
- Regular patient follow-up and Holter-ECG monitoring are essential for managing arrhythmias.
- Echocardiography plays a vital role in the early identification and characterization of this cardiac anomaly.
- Understanding the anatomical substrates of arrhythmias aids in risk stratification and treatment planning.